RELIEF THERAPEUTICS Holding SA

RELIEF THERAPEUTICS Holding SA (SIX: RLF; OTCQB: RLFTF, RLFTY) We are a biopharmaceutical company committed to providing therapeutic relief to patients living with rare diseases. Our goal is to advance treatment paradigms and deliver improvements in efficacy, safety and convenience to benefit the lives of patients and their families. Our therapeutic focus is on rare indications for metabolic disorders, pulmonary diseases, and dermatology/connective tissue disorders.

Website

https://relieftherapeutics.com/

Externer Link zu RELIEF THERAPEUTICS Holding SA

Branche

Biotechnologieforschung

Größe

11–50 Beschäftigte

Hauptsitz

Geneve

Art

Kapitalgesellschaft (AG, GmbH, UG etc.)

Gegründet

2013

Spezialgebiete

Acute Lung Injury, Pulmonary Sarcoidosis, Lung Fibrosis, Acute Respiratory Distress Syndrome, Urea Cycle Disorders, Maple Syrup Urine Disease, Rare Diseases, Epidermolysis Bullosa, Phenylketonuria, PKU, EB, MSUD, UCD, ARDS, Rare Disease, Metabolic Disorders, Acute Lung Disease und Chronic Lung Disease